Fairvalue-Calculator Fairvalue-Calculator
EN DE

Adastra Holdings (XTXXF) Fair Value & Analysis

Healthcare · US · Market cap $39.2K

Price$0.0070
Fair Value$0.0086
Upside+23.0%
Quality92/100
Evidence: Medium Range $0.0086 – $0.0149

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Adastra Holdings (XTXXF) currently trades at $0.0070, while our model-based Fair Value estimate is $0.0086 — implying the stock looks roughly 23.0% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand. It also provides consulting and white label manufacturing. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastra Holdings Ltd. is headquartered in Langley, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Adastra Holdings (XTXXF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0086 versus a price of $0.0070 — about +23% (undervalued). Model-based estimate, not financial advice.
What is the fair value of XTXXF?
Our 21-model fair value for Adastra Holdings is $0.0086 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0070.
What is the quality score of XTXXF?
Adastra Holdings has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.